BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Business

  J.P. Morgan: Will Biotech’s Virtual 2021 Launch Become the New Reality?

  At the annual J.P. Morgan conference, the biotech industry launched its encore to a wildly successful 2020 – virtually. And, as is becoming the common scenario, attendees found both pros and cons to our new (temporary?) reality.

  January 27, 2021

   · 

  5 min read

   · 

  Heather McKenzie
• 

  Business

  Money on the Move: January 21-26

  A brief rundown of who’s raking in cash in the biopharma world.

  January 27, 2021

   · 

  3 min read

   · 

  Kate Goodwin
• 

  Drug Development

  News Brief: J&J Could Supply U.S. with 100 Million COVID-19 Vaccine Doses and More

  J&J indicated it will soon release Phase III data and could file for Emergency Use Authorization with the U.S. Food and Drug Administration by the end of the month.

  January 27, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  Bio NC

  BioSpace Launches 2021 Hotbed Maps to Highlight Thriving Life Sciences Clusters

  See the companies featured in our 2021 maps, explore the territories that are thriving in the life sciences industry, research leading employers and search for relevant jobs on BioSpace.

  January 27, 2021

   · 

  4 min read

   · 

  Ellen Bombela
• 

  Policy

  UPDATE: Bomb Threat Forces Evacuation of AstraZeneca COVID-19 Vaccine Manufacturing Plant

  Police have sealed off the area, according to the report. Few details were available, but eye witnesses said a robot was investigating a suspicious package found at the plant.

  January 27, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  Pharm Country

  Pfizer’s RA Hopeful Fails to Meet Co-Primary Endpoint in Safety Study

  Pfizer announced in a statement on Wednesday that the prespecified non-inferiority criteria for a post-marketing safety study of rheumatoid arthritis (RA) drug XELJANZ® (tofacitinib) were not met.

  January 27, 2021

   · 

  3 min read

   · 

  Brandon May
• 

  Career Advice

  How to Make a New Co-Worker Feel Like a Part of the Team

  Use these ways to immediately make the a new co-worker feel at ease.

  January 27, 2021

   · 

  2 min read

   · 

  Laura Brothers
• 

  BioSpace Global Roundup: Piloxa Evaluates Digital Adherence Solution in CD Patients

  Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.

  January 27, 2021

   · 

  4 min read

   · 

  Alex Keown
• 

  Job Trends

  New Biopharma Job Expansions Help Ring in the New Year

  While many industries are struggling, biopharma is booming. Here’s an overview of last month’s company expansion announcements, who’s growing their footprint and adding more jobs.

  January 27, 2021

   · 

  3 min read

   · 

  Kate Goodwin
• 

  Drug Development

  UK Offers Genomics Expertise to Help Nations ID New SARS-CoV-2 Variants

  On Tuesday, the U.K. offered its genomics expertise to identify emerging variants of the SARS-CoV-2 virus to countries that lack the resources to make such identifications.

  January 27, 2021

   · 

  4 min read

   · 

  Gail Dutton